Research team confirms the long-term safety of methylphenidate in children and adolescents with ADHD

An international research team led by Professor Ian Wong Chi-kei, Head of the Department of Pharmacology and Pharmacy, LKS Faculty of Medicine, the University of Hong Kong (HKUMed) and Professor David Coghill, Department of Pediatrics, University of Melbourne found that long-term methylphenidate treatment does not increase the risk of growth impairments, psychiatric or neurological adverse events in a naturalistic, prospective, controlled, longitudinal study.